Gangolli Julian S 4
4 · Outlook Therapeutics, Inc. · Filed Oct 3, 2024
Insider Transaction Report
Form 4
Gangolli Julian S
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-10-01+56,636→ 56,636 totalExercise: $5.22Exp: 2034-10-01→ Common Stock (56,636 underlying) - Award
Stock Option (Right to Buy)
2024-10-01+71,169→ 71,169 totalExercise: $5.22Exp: 2034-10-01→ Common Stock (71,169 underlying)
Footnotes (2)
- [F1]This option grant is an annual stock option grant under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "2024 Plan") and shall fully vest on October 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control.
- [F2]This option grant was made under the 2024 Plan and shall fully vest on October 1, 2025, subject to the Reporting Person providing continuous service to the Issuer on such date. In addition, the shares underlying the options are subject to acceleration upon a Change in Control as defined in the 2024 Plan, subject to the Reporting Person providing continuous service to the Issuer immediately prior to such Change in Control.